Biotech News

iSpecimen Expands Biospecimen Provider Network

iSpecimen (ISPC)iSpecimen2023-02-08 07:30 ESTCompany update

iSpecimen Strategically Grows its Proprietary Marketplace Platform with Seven New Biospecimen Sample Providers Across the U.S. and Europe

LEXINGTON, Mass., Feb. 08, 2023 (GLOBE NEWSWIRE) -- <a...

iSpecimen

iSpecimen is a healthcare data and biospecimen marketplace company that connects researchers with human biospecimens and related services. Its role is to support research and translational work rather than develop therapies.

Recent company news

ISPCiSpecimen2025-01-16 16:01 EST

iSpecimen Secures Suppliers for COVID-style hMPV Outbreak

ISPCiSpecimen2024-12-20 08:30 EST

iSpecimen Will Serve as a Preferred Provider of Cancer Biospecimens

ISPCiSpecimen2024-12-13 07:30 EST

iSpecimen Reports Positive Results on Next Day Quote Program for Researchers and Providers

ISPCiSpecimen2024-12-12 17:11 EST

iSpecimen Appoints Robert Lim as CEO and Director

ISPCiSpecimen2024-11-08 07:30 EST

iSpecimen Named Top Competitor in $4.4 Billion USD Market

Stock data

Close: 2.20 USD
Market cap: 4.41M USD
Exchange: NASDAQ
Sector: Biopharma
Location: United States